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Background: Meta-analyses of genome-wide association studies (GWAS) have identified single nucleotide
polymorphisms (SNPs) spanning the 5-hydroxytryptamine receptor 4 (5-HT4R) gene (HTR4) associated with lung
function. The aims of this study were to i) investigate the expression profile of HTR4 in adult and fetal lung tissue
and cultured airway cells, ii) further define HTR4 gene structure and iii) explore the potential functional implications
of key SNPs using a bioinformatic approach.
Methods: Following reverse transcription (RT)-PCR in human brain, 5′ rapid amplification of cDNA ends (5′ RACE) was used
to examine the exonic structure of HTR4 at the 5′ end. Quantitative (Q)-PCR was used to quantify HTR4 mRNA expression in
total RNA from cultured airway cells and whole lung tissue. Publically available gene microarray data on fetal samples of
estimated gestational age 7–22 weeks were mined for HTR4 expression. Immunohistochemistry (IHC; in adult and fetal lung
tissue) and a radioligand binding assay (in cultured airway cells) were used to analyze 5HT4R protein expression.
Results: IHC in adult lung, irrespective of the presence of chronic obstructive pulmonary disease (COPD), suggested low
level expression of 5-HT4R protein, which was most prominent in alveolar pneumocytes. There was evidence of differential
5-HT4R protein levels during gestation in fetal lung, which was also evident in gene expression microarray data. HTR4
mRNA expression, assessed by Q-PCR, was <0.5% relative to brain in total adult lung tissue and in human airway smooth
muscle (HASM) and bronchial epithelial cells (HBEC) derived from adult donors. Radioligand binding experiments also
indicated that HBEC and HASM cells did not express a significant 5-HT4R population. 5′ RACE in brain identified a novel N-
terminal variant, containing an extended N-terminal sequence. The functional significance of key HTR4 SNPs was
investigated using the encyclopedia of DNA elements consortium (ENCODE) dataset. These analyses identified multiple
alterations in regulatory motifs for transcription factors implicated in lung development, including Foxp1.
Conclusions: Taken together, these data suggest a role for HTR4 in lung development, which may at least in part explain
the genetic association with lung function.
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5-Hydroxytryptamine (5-HT or serotonin) is a highly
conserved monoamine, which is a major neurotrans-
mitter in the CNS. However, 5-HT is also widely dis-
tributed throughout the periphery, with critical roles
identified in cardiovascular physiology, gastrointestinal
and endocrine function, the regulation of food intake
and energy balance, as well as pulmonary physiology* Correspondence: Ian.Sayers@nottingham.ac.uk
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reproduction in any medium, provided the or[1]. These myriad functions are performed through at
least 15 distinct receptors, grouped into seven struc-
turally and functionally-defined families (5-HT1 – 5-
HT7 receptors, encoded by HTR1-HTR7 genes) [2].
With the exception of the 5-HT3 receptor, which is a
ligand-gated ion channel, these 5-HT receptors (5-
HTRs) are members of the G protein-coupled receptor
(GPCR) superfamily. Further functional diversity arises
from alternative splicing (in the case of 5-HT4R and 5-
HT7R), RNA editing (of the 5-HT2C receptor) and both
homo- and hetero-dimerization involving a variety of
5-HTRs [3,4].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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identified an association between single nucleotide poly-
morphisms (SNPs) localised to a region encompassing the
HTR4 gene and lung function, assessed by forced expira-
tory volume in 1 second (FEV1) and the ratio of FEV1 to
forced vital capacity (FVC) [5-7]. Subsequent studies have
demonstrated an association between this locus and
chronic obstructive pulmonary disease (COPD) [8] and
airflow obstruction in smokers [9].
The complexity of the serotonin receptor family is exem-
plified by the HTR4 sub-family. Encoded by a complex
gene spanning ~200 kb on chromosome 5q33, HTR4 has
at least 10 human splice variants identified to date. Numer-
ous studies in recombinant systems have demonstrated
that alternative splicing of the HTR4 gene can generate re-
ceptor species with distinct pharmacological and functional
profiles, although all couple positively to adenylyl cyclase,
leading to cyclic AMP generation (see [10] for review). The
majority of these splice variants share a common primary
sequence for the first 358 residues, only diverging at the C-
terminus. The exception is 5-HT4hR, which possesses an
additional 14 residues in the second extracellular loop of
the receptor and has been found in combination with the
5-HT4bR C-terminal sequence [11].
HTR4 is highly expressed in the central nervous system,
particularly in limbic structures, where it has been impli-
cated in learning and memory, depression, anxiety and
feeding behaviour [12]. Peripherally, roles for 5-HT4R have
been identified in the gastrointestinal tract, heart, vascula-
ture, adrenal cortex and lower urinary tract [1,13]. Low
levels of HTR4 transcript have also been detected in lung
[6,14,15] and in airway epithelial and smooth muscle cells
[6,16,17].
Given the genetic association data and potential clinical
significance of the HTR4 gene in respiratory physiology
and pathophysiology, we sought to i) investigate the ex-
pression profile of HTR4 in both adult and fetal lung tissue
and in lung tissue from individuals with COPD, ii) define
the gene structure and iii) using the ENCODE dataset, in-
vestigate the potential functional mechanisms underlying
select key HTR4 SNPs associated with lung function. Our
data demonstrate that in adult human lung tissue and iso-
lated cells, including airway smooth muscle and bronchial
epithelial cells, HTR4 expression is very low at both pro-
tein and mRNA levels. Similar findings were observed in
lung tissue isolated from COPD patients. Interestingly, we
identify that 5-HT4R is differentially expressed across de-
velopmental stages, potentially suggesting a role for this
receptor in lung development. Finally, we have identified a
novel splice variant at the N-terminus and multiple poten-
tial regulatory mechanisms, which may underlie the ob-
served HTR4 SNP associations with lung function,
including the alteration of transcription factor binding
sites for factors linked to lung development.Methods
Immunohistochemistry (IHC)
Three undiseased adult lung samples and three lung sam-
ples from individuals with clinically diagnosed COPD were
collected from the Nottingham Health Science Biobank
(Nottingham, UK) with the required ethical approval (08/
H0407/1). Twelve fetal tissue samples were collected from
the Human Developmental Biology Resource (Newcastle
upon Tyne and London, UK, www.hdbr.org) at diverse
stages of development, specifically 19, 21 and 23 days
and 10, 12, 17 and 19 weeks post-conception. Samples were
consented for in accordance with national banking proce-
dures and the UK Human Tissue Act (2004). For all
samples, 4 μm whole tissue sections on glass slides
were de-paraffinized in Histo-clear (National Diagnos-
tics, Dublin, Ireland) and hydrated using decreasing con-
centrations of ethanol. Antigen retrieval was performed in
a steamer for 20 minutes in sodium citrate buffer (pH 6.0),
followed by an endogenous peroxidise block for 5 minutes
(Dako, Cambs, UK). Slides were incubated with either a
rabbit polyclonal anti-5-HT4R antibody (1:500, ab60359,
Abcam, Cambridge, UK) or treated with normal rabbit
IgG as a matched isotype control (Invitrogen/Life Tech-
nologies, Paisley, UK) for 1 hour at room temperature.
The Dako Chemate Envision Detection Kit (Dako) with
DAB chromogen was used for detection. Sections were
then counterstained with Mayer’s Haematoxylin (Sigma-
Aldrich, Dorset, UK), dehydrated and a coverslip mounted
using Vectamount (Vector Laboratories, Peterborough,
UK). Human brain tissue was used as a positive control
for 5-HT4R staining, whilst a negative control substituted
the primary antibody with antibody diluent. Results were
visualized using an Olympus BX14 light microscope.
Cell culture and transfection
All cells were maintained at 37°C in 5% CO2 in a humidi-
fied incubator. Human airway smooth muscle (HASM)
cells were isolated from the healthy bronchial tissue of in-
dividuals without previous asthma history undergoing sur-
gery, and cultured as previously described [18]. Approval
was given by the Nottingham Local Ethical Research
Committee (EC00/165). Undifferentiated human bronchial
epithelial cells (HBEC) (Lonza/Biologics, Slough, UK) were
maintained in culture and differentiated, where relevant,
as previously described [19]. HTR4mRNA expression ana-
lysis was carried out in five HASM (passage 3–5) and four
HBEC (passage 3) donors, while radioligand binding ex-
periments were performed on at least two distinct HASM
and HBEC donors. CHO-K1 cells and the human bron-
chial epithelial cell line BEAS2B-R1 [20] (provided by
Dr. Ray Penn, University of Maryland, Baltimore, USA)
were cultured in Dulbecco’s Modified Eagle’s Medium
supplemented with 10% fetal calf serum (FCS; Sigma-
Aldrich). CHO-K1 cells were transfected (where
Hodge et al. Respiratory Research 2013, 14:77 Page 3 of 13
http://respiratory-research.com/content/14/1/77appropriate) in 24-well plates with a pcDNA3-HTR4a
plasmid (1 μg/well) using FugeneHD transfection reagent
(Promega, Southampton, UK), according to manufac-
turer’s instructions. The pcDNA3-HTR4a plasmid was
constructed by amplifying the protein-coding region of
the HTR4a transcript from total brain RNA (Ambion/Life
Technologies) and inserting this into the EcoRI site of the
pcDNA3 vector. The insert in the resulting plasmid was
sequence-verified as for RT-PCR products (see below).Reverse-Transcription PCR (RT-PCR)
RT-PCR used cDNA synthesised from total RNA using the
Superscript First-Strand Synthesis System for RT-PCR
(Invitrogen/Life Technologies), extracted from cultured
cells or commercially obtained (peripheral blood mono-
nuclear cells (PBMC; 3H Biomedical AB, Uppsala, Sweden),
total lung and brain tissue (both from Ambion/Life Tech-
nologies)). Initial HTR4 expression analysis by RT-PCR
used a forward primer binding in exon 1 (primer 1F, 5′-CA
GCAGAAGCTCGGCTCAG-3′) with reverse primers bin-
ding either in exon 9 (primer 9R, 5′-CTCTCATGGCT
GTCTTCTGG-3′) or exon 13 (primer 13R, 5′-CAATCAG
AAGCATGATTCCAG-3′), with the following cycling pa-
rameters: 35 cycles of 94°C for 1.5 minutes, 60°C for 1.5
minutes, 72°C for 1.5 minutes, followed by 72°C for 10 mi-
nutes. Expression analysis of the novel HTR4 variant tran-
script used a forward primer binding in the novel exon
(primer novel_F, 5′-GAATGGAGAGATCCAGATGG-3′)
and primer 9R, with the following cycling protocol: 94°C
for 2 minutes, then 40 cycles of 94°C for 30 seconds, 55°C
for 30 seconds, 68°C for 1.5 minutes, followed by 68°C for
5 minutes. Amplicons were extracted from agarose gels
using the QIAquick Gel Extraction Kit (Qiagen, Crawley,
UK) and sequence verified using the BigDye Terminator
v3.1 Cycle Sequencing Kit in conjunction with an ABI
PRISM 310 Genetic Analyzer (Applied Biosystems/Life
Technologies).Quantitative PCR (Q-PCR)
Expression analysis of HTR4 was carried out in total RNA
from cultured cells or commercially available total lung
and brain tissue (Ambion/Life Technologies) using TaqMan
methodology for real-time Q-PCR (Applied Biosystems/Life
Technologies) as previously described [19]. In every sample,
Q-PCR was carried out for HTR4 (forward primer 5′-TC
TCTTGCTTTTGCGGATCT-3′, reverse primer 5′-GCAG
AGGGGTCATCTTGTTC-3′, probe 5′-CCCTTTGGTGC
CATTGAGCTGGTTC-3′) and Human TFRC (CD71,
transferrin receptor) Endogenous Control (Applied
Biosystems/Life Technologies). Relative HTR4 expression
was calculated using the 2-ΔΔCt method [21], corrected
using the endogenous control (TFRC) and displayed rela-
tive to expression in total brain tissue.Affymetrix U133 Plus 2 array data for human fetal lung
Publically available data [22,23] were utilized to see
whether HTR4 was differentially expressed during normal
human lung development. Previously, human fetal lung
tissues were obtained from National Institute of Child
Health and Human Development tissue databases and
microarray profiled to investigate the expression spanning
different gestational ages. RNA samples from 38 subjects
(estimated gestational age 7–22 weeks or 53–154 days
post conception) i.e. Pseudoglandular (gestational age, 7–
16 weeks) and Canalicular (17–26 weeks) stages of devel-
opment were included within the dataset. These data are
available at NCBI Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo), GSE14334. The dataset
was mined for HTR4 expression using Affymetrix probes;
216939_s_at, 207577_at and 207578_s_at.
Radioligand binding
CHO-K1 cells were plated into 24-well plates and grown
for 24 hours in DMEM containing 10% FCS prior to
transfection. BEAS2B-R1, HBEC and HASM cells were
plated into 24-well plates 24–48 hours prior to experi-
mentation. Experiments were performed 48 hours post-
transfection in HEPES-buffered saline (HBS: 20 mM
HEPES, 150 mM NaCl, 4.2 mM KCl, 0.9 mM CaCl2, 0.5
mM MgCl2, 0.1% glucose, and 0.1% bovine serum albu-
min), as previously reported [24]. The reaction mixture
(250 μl) containing saturating concentrations of [3H]-
GR113808 (approx. 1 nM, Kd = 0.30 nM; specific activ-
ity, 83 Ci/mmol) was added to the cells and incubated
for 2 hours at 4°C. Non-specific binding was defined in
the presence of 5-HT (10 μM). Incubation was termi-
nated by aspiration, followed by washing the cells with
ice-cold HBS (2 × 1 ml). Cells were lysed in 0.1 M
NaOH, then 10 ml of scintillation liquid (UltimaGold XR
scintillation cocktail; Perkin Elmer, Bucks, UK) was added
and radioactivity was measured by scintillation counting.
Protein concentration was determined using a Bio-Rad
protein assay (Hercules, California, USA), allowing recep-
tor densities (in fmol/mg protein) to be determined.
5′ Rapid amplification of cDNA Ends (5′ RACE)
Total RNA was extracted from cultured cells using the
RNeasy Mini Kit (Qiagen) or obtained from commercial
sources. RACE-ready cDNA was synthesised using total
RNA from HASM, undifferentiated and differentiated
HBEC, PBMC (3H Biomedical AB) and total lung and brain
tissue (Ambion/Life Technologies) using the GeneRacer Kit
(Invitrogen/Life Technologies). 5′ RACE used GeneRacer
primers as well as HTR4-specific nested primers for amp-
lification. PCR products generated were then cloned using
the pGEM-T Easy Vector System (Promega) to identify
exon structure at the 5′ end of the gene. RACE clones
were sequenced using the BigDye Terminator v3.1 Cycle
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Genetic Analyzer (Applied Biosystems/Life Technologies).
Sequences were aligned with the ‘Human Genomic +
Transcript’ database using the Basic Local Alignment
Search Tool (BLAST) provided by the National Center
for Biotechnology Information (NCBI, http://www.ncbi.
nlm.nih.gov/). Protein structures were predicted from
5′ RACE data using online tools: the TMHMM Server
v. 2.0 [25] and TOPO2, provided by the Sequence Ana-
lysis & Consulting Service at UCSF (http://www.sacs.
ucsf.edu/cgi-bin/open-topo2.py/).
Bioinformatic analysis
The HTR4 gene was annotated with RNA sequencing,
H3K27Ac histone marks, DNase I hypersensitivity,
transcription factor binding (all derived from the UCSC
encyclopedia of DNA elements consortium (ENCODE)
database [26]), CpG island and placental mammal
conservation tracks using the UCSC genome browser
(http://genome.ucsc.edu/) on the Human Feb 2009
(GRCh37/hg19) assembly [27,28]. The predicted effects
of polymorphisms (in the HapMap CEU cohort, as
of December 2012) in linkage disequilibrium (LD)Figure 1 Immunohistochemistry of 5-HT4R in normal adult human lun
was found in the pneumocytes of the alveoli in all three normal lung samp
weak cytoplasmic staining (g), donor 2 had strong cytoplasmic and nuclea
<20% of epithelial cells (i). All isotype controls were negative (d-f and j-l).(r2>0.80) with the sentinel HTR4 SNP (rs3995090)
identified in the SpiroMeta lung function GWAS [6]
were examined using the HaploReg database (http://
www.broadinstitute.org/mammals/haploreg/) [29].
Results
5-HT4R is expressed at low levels in adult human lung tissue
Immunohistochemistry performed with an anti-5-HT4R
antibody in normal lung tissue from three donors identi-
fied specific staining for 5-HT4R in alveolar pneumocytes
(Figure 1a-c). The staining in these cells was both cyto-
plasmic and membranous, which is consistent with the
anticipated sub-cellular expression profile for a GPCR.
Some specific 5-HT4R staining was also detected in
bronchial epithelial cells, but substantial variation be-
tween donors was observed in this location. While
strong staining was observed in the epithelial cells of
donor 2 (Figure 1h), only weak staining was observed in
the other 2 donors (Figure 1g and 1i). In addition, the
strong staining in donor 2 was cytoplasmic and nuclear,
with little apparent staining at the plasma membrane
(Figure 1h). No staining was observed in any of the
isotype controls (Figure 1d-f and 1j-l).g tissue. Low cytoplasmic and membranous expression of 5-HT4R
les (a-c). The epithelium showed variable staining; donor 1 had very
r staining of >50% of nuclei (h), whilst donor 3 had weak staining in
X40 magnification.
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tissue from individuals with COPD
5-HT4R protein expression was analyzed by IHC in
three COPD donors. Donor 1 (COPD1) was a 61 year
old female, heavy smoker with moderate COPD; donor
2 (COPD2) was a 55 year old male, heavy smoker with
severe COPD; donor 3 (COPD3) was a 48 year old fe-
male, heavy smoker with severe COPD. Weak 5-HT4R
immunopositivity was found in the nuclei and cyto-
plasm of pneumoctyes in the alveolar regions of all
three COPD samples (Figure 2a-c). The epithelium
showed variable staining between donors: COPD1
had weak nuclear staining (Figure 2g), COPD2 had
moderate nuclear and cytoplasmic staining (Figure 2h)
whilst COPD3 was negative for the 5-HT4R protein
(Figure 2i). All isotype controls were negative (Figure
2d-f and 2j-l).5-HT4R is differentially expressed during fetal
development at the protein and mRNA level
Fetal tissue spanning ages 19 days-19 weeks was
investigated using IHC (Figure 3). These data
demonstrated a trend towards an increase in 5-HT4R
protein expression spanning Embryonic (Figure 3a-f) toFigure 2 Immunohistochemistry of 5-HT4R in COPD lung tissue. Weak
the alveolar regions of all COPD samples (a-c). In the bronchial epithelium COP
cytoplasmic staining (h) whilst COPD3 was negative for the 5-HT4R protein (i). APseudoglandular (Figure 3g-j) stages and a potential
decrease in the Canalicular (Figure 3k-l) stage of
development. Staining was predominantly nuclear
and widespread across the airway epithelium. The
gene array data demonstrated that there was
a significant increase in expression levels with age
during the Pseudoglandular (gestational age, 7–16
weeks) and Canalicular (17–26 weeks) stages of de-
velopment, with one of the Affymetrix probes
(207577_at) surviving correction for false discovery
rate (Table 1). These data suggest that an increase in
5-HT4R expression is a feature of lung development
with a lower level of protein expression in subse-
quent stages, potentially reflecting the levels observed
in the adult lung.
Analysis of HTR4 gene structure in brain and HTR4
expression profiling in airway cells by Q-PCR and
radioligand binding
Previously described gene arrangements for HTR4 are
summarized in Figure 4. Transcripts a, b, i, d and g are
currently reported by NCBI (December 2012); transcripts
h, n, e, f and c have been described in the literature [10].
These data illustrate the complex splicing that exists at
this gene locus, including multiple functionally relevant C-5-HT4R staining was found in the nuclei and cytoplasm of pneumoctyes in
D1 had weak nuclear staining (g), COPD2 had moderate nuclear and
ll isotype controls were negative (d-f and j-l). X40 magnification.
Figure 3 Immunohistochemistry of 5-HT4R in fetal lung tissue. Weak staining is apparent in early Embryonic stages which increases in
intensity with age leading to strong staining in the Pseudoglandular and moderate staining in the Canalicular stages. a-l represent age ordered
samples of 19 days (a, b), 21 days (c, d), 23 days (e, f), 10 weeks (g, h), 12 weeks (i, j), 17 weeks (k) and 19 weeks (l). All isotype controls were
negative (data not shown). X40 magnification.
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signalling responses [10]. Analysis by RT-PCR indicated
expression of mRNA encoding HTR4 in total brain tissue,
but failed to detect expression in HASM, undifferentiated
HBEC, PBMC or total lung tissue (data not shown).
Targeted sequencing of PCR products derived from brain
cDNA confirmed the presence of both variants a (acces-
sion NM_001040169.2) and b (accession NM_000870.5),
distinguished by the presence of exons 9 and 13 respect-
ively. Additionally, exon 1 was present in variant a, al-
though this contradicts data currently reported by NCBI
(Figure 5a). Q-PCR data indicated very low levels of mean
HTR4 mRNA expression in airway cells and tissues when
compared to total brain tissue: total lung (0.26%), undiffer-
entiated HBEC (0.05%), HASM (0.02%) and BEAS2B-R1
(0.16%) (Figure 5b).
In addition, radioligand binding (using the highly 5-HT
4R-selective ligand [
3H]-GR113808 [24]) failed to detect
any significant 5-HT4R expression in undifferentiated
HBEC (none detected; n = 3), HASM (14.1 ± 13.2 fmol/
mg protein; n = 4) or BEAS2B-R1 (50.1 ± 36.6 fmol/mg
protein; n = 3) cells (Figure 5c), in good agreement with
the Q-PCR data in these cell types. In contrast, a substan-
tial 5-HT4R population could be detected in CHO-K1 cellsTable 1 Fetal lung gene array data for HTR4 expression
during Pseudoglandular and Canalicular stages of lung
development
Probe ID AveExpr t P.value Adj.p.val Beta-coefficient
216939_s_at 3.2999 0.9672 0.3393 0.5156 0.0009
207577_at 3.6980 3.3242 0.0019 0.0121 0.0024
207578_s_at 7.0472 0.3855 0.7020 0.8160 0.0008
AveExpr, average expression between all samples; t, t-statistic describing
differential expression; P.Value, Unadjusted p value; adj.P.Val, Adjusted p value
controlling for false discovery rate; Beta-coefficient= log-odds ratio
(corresponding to the mean change in gene expression per day during the
studied period, 7–22 weeks of gestational age).transiently transfected with pcDNA3-HTR4a (460.7 ± 69.3
fmol/mg protein; n = 4), but not in un-transfected CHO-
K1 cells (8.3 ± 7.8 fmol/mg protein; n = 4). These data
suggest that there is limited 5-HT4R expression in cul-
tured structural cells of the adult lung, in agreement with
the low levels of IHC staining for 5-HT4R in adult lung
tissue.
5′ RACE showed variation of HTR4 transcripts in
cDNA derived from total brain tissue only; it was not pos-
sible to amplify HTR4 transcripts from total lung tissue,
HASM, HBEC (undifferentiated and differentiated) and
PBMC due to the extremely low abundance. Approxi-
mately half of the analyzed clones derived from brain
cDNA showed the presence of exons 1–3, although exon
1 was truncated by 41bp at the 5′ end compared to the se-
quence reported by NCBI (Figure 6a). The remaining
clones possessed a novel exon of 107bp, in place of exons
1 and 2. Two consecutive RT-PCR procedures in cDNA
derived from total brain, i.e. using the amplicon from the
first as a template in a second, and confirmation by se-
quencing showed that the exonic structure of the novel
exon-containing variant was comparable to transcript b,
since sequence alignment was of good quality for con-
secutive exons 3, 4, 5, 7 and 9 (Figure 6b). However,
consecutive RT-PCR procedures failed to detect this
novel transcript in total lung tissue or differentiated
HBEC (data not shown). Using BLAST, we found that
the sequence of the novel exon aligns with a region on
the same genomic contig as the HTR4 gene (accession
NG_029052.1). Using the same translational stop codon
as that in transcript b, the novel transcript variant has
an in-frame translational start codon (ATG) within this
novel exon. The predicted protein structure of the novel
transcript has an extended N-terminus (Figure 6c). Fur-
thermore, the N-linked glycosylation site in the N-ter-
minal region of transcript b is replaced in the novel
transcript by an alternate site further upstream.
Figure 4 Known HTR4 transcript variants. Transcripts a, b, i, d and g are currently reported by NCBI (December 2012); translational stop
positions are indicated by red arrows. Transcripts h, n, e, f and c have been described in the literature [11,15,30-32].
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dataset
Annotation of the region containing the HTR4 gene
(shown in Figure 7) illustrates the regulatory elements
contained within this region, as predicted by the ENCODE
database. There are no obvious CpG islands in this region,
however substantial DNase I hypersensitivity clusters,
transcription factor binding sites (identified by ChIP-seq)
and H3K27Ac marks (at least in HUVEC and K562
erythroleukemia cells) are identified within the 3′ end of
the HTR4 gene. These regulatory features coincide with
the region containing the variants in linkage disequlibrium
(LD) (r2>0.80) with the sentinel SNPs (rs3995090 and
rs6889822) identified in the SpiroMeta lung function
GWAS [6], as indicated in Figure 7. Less pronounced his-
tone modification peaks, in addition to clusters of tran-
scription factor binding and DNase I hypersensitivity sites
are found towards the 5′ end of the HTR4 gene. Using the
HaploReg database focussed to one of the sentinel SNPs
(rs3995090) identified in the SpiroMeta lung function
GWAS [6], we found that this SNP was in LD (r2>0.80)
with an additional 28 SNPs in the 1000 Genomes dataset,
which included the second sentinel SNP rs6889822
(r2>0.96) (Additional file 1: Table S1). We identified a wide
range of alterations associated with these SNPs in: i)enhancer histone marks, ii) DNase I hypersensitivity sites,
iii) proteins bound and iv) regulatory motifs. Of note,
three of the SNPs (rs7733088, rs4705259 and
5:147836450) in LD (r2>0.80) with sentinel SNP
rs3995090 significantly alter Foxp1 binding motifs within
the HTR4 gene (Additional file 1: Table S1). The Fox fam-
ily of transcription factors are key regulators of lung
development.
Discussion
The translation of GWAS findings to human biology re-
mains a challenge. In the current study we have begun
to interpret our recent finding that SNPs spanning the
HTR4 gene are associated with FEV1 in the general
population [6]. To this end we have extensively expres-
sion profiled the 5-HT4R protein and HTR4 mRNA in
human lung tissue and cells. We identified that 5-HT4R
protein is only weakly expressed in the adult human
lung, irrespective of the presence of COPD. In agree-
ment, we identified very low levels of HTR4 mRNA and
were unable to detect a significant 5-HT4R population
in cultured airway structural cells, including bronchial
epithelial and airway smooth muscle cells. Interestingly,
when we investigated 5-HT4R in human fetal lung tissue
we identified a robust level of protein expression that
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Figure 5 Expression profiling of HTR4 in airway cells. RT-PCR and sequencing confirmed expression of HTR4 transcripts a (NM_001040169.2) and
b (NM_000870.5) in total brain tissue (a). Sequence encoding exon 1 was found in both transcripts, which contradicts information provided by NCBI
for transcript a, however transcripts a and b were differentiated by the presence of exon 13 or 9 respectively. Q-PCR analysis (b) indicated highest
expression in total brain tissue, but ≤0.26% relative to this in total lung tissue, HBEC, HASM and the BEAS2B-R1 cell line. Error bars indicate SEM (n ≥3).
Radioligand binding experiments (c), using a saturating concentration of [3H]-GR113808 (approx. 1 nM), defined 5-HT4R expression in CHO-K1 cells
transiently transfected with pcDNA3-HTR4a, un-transfected CHO-K1 cells, HBEC, HASM and BEAS2B-R1 cells. Error bars indicate SEM (n ≥3). While the
pcDNA3-HTR4a-transfected CHO-K1 cells expressed a substantial 5-HT4R population (approx. 460 fmol/mg protein), no other cell type expressed a
significant receptor population (all ≤50 fmol/mg protein).
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velopment. In agreement, gene expression array data
also showed differential HTR4 mRNA lung expression
levels across gestational stages. These data are novel and
potentially suggest a role for HTR4 in lung development.
We also identified a novel N-terminal splice variant in
brain with potential implications for 5-HT4R function. Fi-
nally we investigated the functional relevance of key
genome-wide significant SNPs and identified multiplepotential functional mechanisms e.g. through the alter-
ation of developmental transcription factor binding
motifs.
The very low level of HTR4 mRNA detected in lung in
the present study is consistent with a number of previous
studies. For instance, Bach et al. [14] used RT-PCR to
screen a variety of tissues for the expression of HTR4a
and HTR4b and successfully detected both in a number of
tissues (e.g. brain and colon). However, they only showed
Figure 6 Analysis of HTR4 gene structure and identification of a novel transcript variant in brain. 5′ RACE in cDNA derived from total
brain tissue indicated expression of transcripts possessing exons 1-3, and also a novel transcript in which exons 1 and 2 are replaced by an
alternate exon (a). The remaining sequence of the novel transcript aligns with the equivalent region of transcript b (b). The predicted protein
structure of this novel variant has an elongated N-terminus and affects the position of an N-linked glycosylation site in this region (c).
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detect HTR4a at all) in the lung. Medhurst et al. [33]
employed a Q-PCR approach using a pan HTR4 PCR
assay and detected only very low levels of HTR4 in lung.
In contrast, Brattelid et al. [15] were able to detect both
HTR4a and HTR4b in lung by RT-PCR, while Q-PCR
identified HTR4a, HTR4b and HTR4g in the same tissue.
Specifically in airway smooth muscle cells, a gene micro-
array study identified HTR4g as the only significant HTR4
species [17]. Together with our findings in control and
COPD subjects, the consensus from the literature would
suggest that HTR4 is expressed in adult lung, albeit at very
low levels.
The majority of the literature is limited to whole lung
HTR4 expression so, in addition to human lung tissue, we
chose to focus on two specific, functionally and clinically
relevant primary airway cell types (cultured human bron-
chial epithelial cells (HBEC) and airway smooth muscle
cells (HASM)), as well as the human bronchial epithelialcell line BEAS2B-R1, to investigate whether HTR4 was
enriched within a specific lung cell type. We observed
similar (or even lower) levels of HTR4 mRNA in these in-
dividual cell types as in whole lung. We also failed to de-
tect a significant level of expression at the protein level
(using [3H]-GR113808 radioligand binding) in these cells,
despite successfully detecting robust 5-HT4R expression
in pcDNA3-HTR4a-transfected CHO-K1 cells. Since
[3H]-GR113808 has also previously been used to measure
relatively low levels of endogenous 5-HT4R expression
(60–223 fmol/mg protein) in human brain regions [34],
our findings suggest that there is little enrichment of 5-
HT4R in bronchial epithelial and airway smooth muscle
cells. While the radioligand and IHC approaches to deter-
mine 5-HT4R protein levels in airway structural cells are
in broad agreement, we cannot exclude that the lack of 5-
HT4R protein expression observed in cultured cells is due
to loss of receptor expression during passage. Bayer et al.
[16] have previously identified HTR4 expression in
Sentinel SNPs (and SNPs r2>0.80) associated with lung function
Figure 7 Regulatory motifs and lung function-associated single nucleotide polymorphisms (SNPs) within the HTR4 gene.
HTR4 annotated with RNA sequencing, H3K27Ac histone marks, DNase I hypersensitivity, transcription factor binding, CpG island and placental
mammal conservation tracks (UCSC genome browser (http://genome.ucsc.edu/)) on the Human Feb 2009 (GRCh37/hg19) assembly. For the
H3K27Ac histone marks and RNA sequence tracks, peak height is proportional to signal amplitude, with colours representing data sets in different
cell backgrounds (pale blue H3K27Ac histone trace = human umbilical vein endothelial cell (HUVEC); blue/grey = K562 erythroleukemia cells).
For the DNase I hypersensitivity and transcription factor binding tracks, a grey band indicates the extent of the hypersensitive region and the
darkness of the band is proportional to the maximum signal strength observed in any cell line. The positions of HTR4 variants in LD (r2>0.80) with
the sentinel SNP (rs3995090) identified in the SpiroMeta lung function GWAS [6] are also shown, with the top 2 ranking SNPs (rs3995090 and
rs6889822) indicated in red.
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mary type II alveolar pneumocytes by RT-PCR, providing
evidence for expression of HTR4 in airway epithelial cells
(albeit cell lines). Our immunohistochemical data indicate
the strongest 5-HT4R protein expression in alveolar
pneumocytes, with only weak and variable expression in
bronchial epithelial cells. Taken together, these findings
suggest that the main site of 5-HT4R expression in adult
lung may be in alveolar pneumocytes.
In contrast to the adult human lung analyses, we ob-
served clear, robust staining for 5-HT4R in the fetal lung
tissue using immunohistochemistry. The predominantly
nuclear localization of 5-HT4R in lung tissue suggests that
the protein could have distinct roles during development,
possibly beyond the scope of a classical plasma membrane-
localized GPCR. Interestingly, there is a growing body
of evidence for the nuclear localization and function of
endogenous GPCRs in a variety of systems (see [35] for
review). Notwithstanding the predominantly nuclear
localization, our qualitative data identified a differential
expression of 5-HT4R with gestational age, with the in-
tensity of staining being particularly prominent in the
Pseudoglandular stage of lung development. In agree-
ment, using more quantitative mRNA data, differential
expression through development was observed, withelevated HTR4 expression across the Pseudoglandular
(7–16 weeks) and Canalicular (17–26 weeks) stages. Al-
though both immunohistochemical protein and expres-
sion array mRNA data indicate that there is differential
HTR4 gene expression during lung development, the
timing of the increase in expression differs between
mRNA (higher expression during the Canalicular stage)
and protein (peak expression in the Pseudoglandular
stage). For the gene expression microarray analysis, 26
samples in the Pseudoglandular stage (specifically 53 – 110
days post-conception) and 12 samples in the Canalicular
stage (specifically 113 – 154 days post-conception) contrib-
uted to these analyses, whereas tissue used for immunohis-
tochemistry included 4 samples at the Pseudoglandular
stage (70 – 94 days post-conception) and only 2 samples at
the Canalicular stage (specifically 119 and 133 days post-
conception). It is, therefore, possible that the differences in
sample sizes and/or sample cohorts used in the two ana-
lyses could underlie this discrepancy.
Nonetheless, these lung-specific data are novel and
suggest HTR4 is likely to be of relevance to lung devel-
opment. Of interest, differential 5-HT4R protein expres-
sion during human hypothalamus development has been
described, with the appearance of 5-HT4R being associ-
ated with the later stages (31–32 weeks) of development
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ceptors has also been shown in the prefrontal cortex
during post-natal development, again with elevated 5-
HT4R expression reported during the later stages [37].
Taken together these data suggest a role for HTR4 in the
development of multiple human tissues.
The low level of HTR4 mRNA detected in adult lung
precluded a thorough investigation of the splice variant
expression profile in human airways. However, there is ex-
tensive evidence for functionally relevant HTR4 splicing,
in particular at the C-terminus [10]. In brain, we were able
to successfully perform 5′ RACE, which indicated signifi-
cant expression of a previously un-reported HTR4 splice
variant, arising from the replacement of exons 1 and 2 by
a novel exon. The resulting variant is predicted to possess
an extended N-terminus (14 amino acids longer than the
other 5-HT4R isoforms) and a distinct N-glycosylation site
(at position 2 in the novel variant, as opposed to position
7 in all other reported human 5-HT4R variants). Interest-
ingly, although our findings represent the first example of
variation at the N-terminus of the human 5-HT4R, several
transcripts encoding different N-termini have been identi-
fied in mouse brain [38]. Sequence predictions based upon
these novel transcripts indicated changes in N-terminal
length and in some cases altered phosphorylation, acetyl-
ation and glycosylation sites [38], highlighting parallels
with our own findings in human brain. N-terminal struc-
ture and in particular the N-glycosylation of GPCRs may
influence a range of receptor functions, including the traf-
ficking of receptors to the cell surface, ligand binding, re-
ceptor activation and down-regulation [39].
SNPs within HTR4 have been associated with lung func-
tion [5,6] and COPD/airway obstruction [8,9] in several
populations. Recently, HTR4 SNPs have also been associ-
ated with asthma in a Korean population, with the most
significant associations localized to introns within HTR4
that were previously identified in the SpiroMeta/CHARGE
lung function meta-analyses [5,6,40]. However, large scale
analyses of asthma utilizing 10,365 asthma and 16,110 un-
affected controls as part of the GABRIEL study did not
identify an association for HTR4 SNPs [41].
The functional relevance of associated HTR4 SNPs re-
mains to be determined, however the potential localization
of the key SNPs (i.e. rs3995090 and rs6889822) from the
SpiroMeta lung function meta-analyses to intron 6 of the
gene (variant a) provided an initial focus for the current
study. The ENCODE database identified a number of fea-
tures within this locus (histone modifications, DNase I
hypersensitivity clusters and transcription factor binding
sites) consistent with a regulatory region. Interestingly,
according to the HaploReg database, three of the SNPs
(rs7733088, rs4705259 and 5:147836450) in LD (r2>0.80)
with the sentinel SNP (rs3995090) identified in the
SpiroMeta lung function GWAS significantly alter Foxp1binding motifs within HTR4. The Fox family of transcrip-
tion factors are key regulators of lung development. In
particular, the sub-family of Foxp1/2/4 is highly expressed
in the developing airway epithelium, as well as in the adult
lung [42]. Foxp1 and Foxp2 co-operatively regulate distal
lung epithelial development [43], while Foxp1 and Foxp4
together modulate lung secretory epithelial cell fate during
development and regeneration, by restricting the goblet
cell differentiation program [44]. Given the presence of a
Foxp1 binding motif within the region of HTR4 associated
with lung function, it is tempting to speculate that Foxp1
binding in this locus might be important in regulating
HTR4 during lung development.
Influences on airway growth during development can
have long-term physiological effects within the lung [45].
Our data suggest that HTR4 is differentially expressed in
the developing lung. When taken together with the finding
that SNPs in LD with those associated with lung function
alter transcription factor binding sites for factors known
to be involved in lung development, our results suggest
that HTR4 expression may be important for lung develop-
ment. In agreement with this interpretation, it is import-
ant to note that the association between HTR4 SNPs and
lung function was apparent in children included in GWAS
meta-analyses of lung function, e.g. in the ALSPAC (Avon
Longitudinal Study of Parents and Children) and in the
Raine Studies [6,7].
It is also important to note that a role for 5-HT4R
in post-natal lung related functions has been described
including: the modulation of cytokine release in human
alveolar type II cells [16], influencing the effect of 5-HT
on cholinergic contraction in human bronchial strips
[46] and bronchopulmonary C-fibre mediated cough
and dyspnea [47]. Similarly, 5-HT4R is expressed in the
pre-Bötzinger complex in the CNS, and has been dem-
onstrated to regulate spontaneous respiratory activity
[48].
Conclusions
In summary, we have demonstrated that HTR4 is ex-
pressed at the mRNA and protein level in adult lung tis-
sue, albeit at a low level, using both normal and COPD
lung tissue sections and cultured airway cells. The analyses
of lung tissue from different fetal stages of development
highlight differential expression of HTR4 at the protein
and mRNA level, suggesting a developmental role. Intri-
guingly, we have also identified that the key SNPs in
HTR4 associated with lung function also potentially alter
binding of a series of key transcription factors of relevance
for the development of multiple organs. Finally, we further
characterized the gene structure of HTR4, identifying in
brain a novel splice variant with potential functional impli-
cations. These data represent a significant advance in our
knowledge of the role of HTR4 in the lung and provide
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